ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
J Infect Dis
; 228(Suppl 2): S77-S82, 2023 08 31.
Article
en En
| MEDLINE
| ID: mdl-37650231
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Pacientes Ambulatorios
/
COVID-19
Idioma:
En
Revista:
J Infect Dis
Año:
2023
Tipo del documento:
Article